NS1 Protein Could Be Vital Target To Develop New Drugs To Treat Dengue

Brazilian scientists have discovered the mechanism that dengue virus uses to bind with human enzyme to replicate and spread faster in the body.

NS1 is one of the seven proteins composing the dengue virus and more specifically its replication machinery.

Surprisingly! Dengue Virus Serotypes More Likely to Have Distinctive Antigenic Variations
Characterizing the global variation of dengue viruses will be important for understanding where current vaccines will be protective in humans.

It is an abundant protein detected in the serum of infected patients and used as a target for early detection.Without NS1, the virus cannot replicate whereas NS1 mutation decreases virus yield.

Using a unique technique, the team found that the viral protein that NS1 binds to is well-known to any cell biologist is called "GAPDH".

GAPDH is an enzyme involved in process where the glucose is broken down to generate energy in humans.

AIIMS to Start Serological Tests to Identify Prevalent Strains of Dengue Virus in India
Over 6,000 cases of dengue, 885 of them in August alone its the highest record in the capital since 2010, but the symptoms were found to be relatively milder.

The enzyme is ubiquitous and very abundant in animal cells and is also involved in non-metabolic processes such as control of gene expression.

Because GAPD is so abundant in the cell, the group also performed other complementing tests to confirm that the binding between NS1 and GAPDH is specific and not a spurious finding.

Union Health Ministry Urges AIIMS on Precise Identification of Dengue Virus Subtype
All four serotypes of dengue were isolated in various states and the report of the serotypes circulating in Delhi is expected within a week by the Ministry.

"As obligatory parasites, viruses rely on the host metabolism to obtain what they need to generate their progeny. We show that in human cells, NS1 binds to GAPDH as a way to increase energy production to be used for viral replication," explained Dr Ronaldo Mohana Borges from the Federal University of Rio de Janeiro (UFRJ).

Indeed, energy production modulation is a remarkable feature that improves the energy supply required for supporting active viral replication, he added.

A New Approach to Fight Dengue Virus: Create Immunity Without Vaccination
Though vaccines are being developed to fight the virus, none provides balanced protection against all four strains of the dengue virus.

The authors hypothesize that NS1 modulates the host metabolism by increasing GAPDH activity early on in the course of infection and, thus, should be considered as an important target for the development of new drugs to treat dengue.

Dengue is a mosquito-borne tropical disease currently endemic in more than 10 countries, including India.

According to the World Health Organization (WHO), 390 million people are infected by dengue every year.

The disease can be caused by one of the four types of dengue virus transmitted by the Aedes aegypty mosquito, the main vector for dengue.

In humans, symptoms of dengue infection include fever, headache, muscle and joint pain and a characteristic skin rash.

In some cases, dengue infection can take a dangerous turn and develop into a life-threatening hemorrhagic fever and dengue shock syndrome.

The paper has been published in the Journal of Virology.

Source-IANS